{
    "clinical_trials": [
      {
        "id": "NCT01719380",
        "title": "BEACON CRC Study: A Phase 3 Trial of Encorafenib and Cetuximab With or Without Binimetinib",
        "phase": "3",
        "status": "Completed",
        "locations": ["United States", "Europe", "Asia"],
        "startDate": "Oct 2016",
        "primaryCompletion": "Feb 2019",
        "interventions": ["Encorafenib", "Cetuximab", "Binimetinib"],
        "url": "https://clinicaltrials.gov/ct2/show/NCT01719380"
      },
      {
        "id": "NCT04044430",
        "title": "A Study of Encorafenib Plus Cetuximab in Subjects With Previously Untreated BRAF V600E-Mutant Metastatic Colorectal Cancer",
        "phase": "2",
        "status": "Recruiting",
        "locations": ["MD Anderson Cancer Center", "Mayo Clinic", "MSKCC"],
        "startDate": "Aug 2019",
        "primaryCompletion": "Dec 2023",
        "interventions": ["Encorafenib", "Cetuximab"],
        "url": "https://clinicaltrials.gov/ct2/show/NCT04044430"
      }
    ]
  }
  